Dr. David Benjamin Beck, MD, PhD

Dr. Beck practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Beck's NPI, 1235558917, was assigned on April 10, 2014. Dr. Beck graduated from New York University School of Medicine in 2014. Dr. Beck holds New York license 311033.

Dr. Beck's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-3130.

Dr. Beck's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Beck is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Beck to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beck practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Beck's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Beck is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Beck's licenses on file in 3 states: New York, District of Columbia and Virginia.

Dmand AI lists joint arthropathy among the conditions Dr. Beck treats.

CMS data shows 57 Medicare services from Dr. Beck across 2 procedure codes in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $9,132 for them. Every service was in an office.

CMS counts 24 Medicare patients who saw Dr. Beck in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high cholesterol, and 71% have arthritis. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beck's median patient age at 66, with 30% women.

In 2024, Dr. Beck wrote 22 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $259 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Beck for performance year 2024, reported as part of a group. Dr. Beck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beck as offering telehealth.

Dmand AI links 78 papers to Dr. Beck, published from 2010 to 2025. 2021 was the busiest year, with 10. The most frequent topics are Ubiquitin-Activating Enzymes, Inflammation and Myelodysplastic Syndromes. Dr. Beck has published most often in Arthritis Rheumatol. Dr. Beck's most frequent co-authors are Amanda Kilker Ombrello, MD, Neal Stuart Young, MD and Wendy Chung, MD.

CMS Open Payments shows 13 general payments to Dr. Beck from 5 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 98% of the total. Sobi, Inc paid the most, $9,846. It also lists 4 research payments totaling $1,789 in 2025.

Dr. Beck graduated from New York University School of Medicine in 2014.

Dr. Beck is in network with 18 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.